Next Article in Journal
Variations in Antibiotic Use and Sepsis Management in Neonatal Intensive Care Units: A European Survey
Next Article in Special Issue
Iriflophenone-3-C-β-d Glucopyranoside from Dryopteris ramosa (Hope) C. Chr. with Promising Future as Natural Antibiotic for Gastrointestinal Tract Infections
Previous Article in Journal
Topically Applied Bacteriophage to Control Multi-Drug Resistant Klebsiella pneumoniae Infected Wound in a Rat Model
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antibiotics
Volume 10
Issue 9
10.3390/antibiotics10091049
antibiotics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synergistic Anticandidal Effects of Six Essential Oils in Combination with Fluconazole or Amphotericin B against Four Clinically Isolated Candida Strains

by
Bouchra Soulaimani
1,
Elena Varoni
2,
Marcello Iriti
3,*,
Nour-Eddine Mezrioui
1,
Lahcen Hassani
1 and
Abdelaziz Abbad
1
1
Laboratory of Microbiology and Biotechnology, Agrosciences and Environment, Faculty of Sciences Semlalia, Cadi Ayyad University, Marrakech 40000, Morocco
2
Department of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, 20142 Milan, Italy
3
Department of Agricultural and Environmental Sciences, Università degli Studi di Milano, 20133 Milan, Italy
*
Author to whom correspondence should be addressed.
Antibiotics 2021, 10(9), 1049; https://doi.org/10.3390/antibiotics10091049
Submission received: 25 July 2021 / Revised: 22 August 2021 / Accepted: 25 August 2021 / Published: 27 August 2021
(This article belongs to the Special Issue Antimicrobial Plant Extracts and Phytochemicals, 2nd Volume)
Versions Notes

Abstract

:
The development of opportunistic pathogenic Candida strains insensitive to several classes of antifungals has emerged as a major health care problem during the last years. Combinational therapy of natural products (e.g., essential oils, EOs) with conventional antifungals has been suggested as a promising alternative to overcome this medical problem. The present study investigates the potential antifungal activity of EOs extracted from some selected medicinal plants, alone and in combination with two common conventional antifungals (fluconazole and amphotericin B) against four clinical Candida isolates. MIC assays indicated that EOs induced strong anticandidal activities with MIC values ranging from 0.162 to 4.950 mg/mL. The combination of amphotericin B with Thymus leptobotrys, Origanum compactum and Artemisia herba alba EOs provided a synergistic effect against C. krusei only, with MIC gain of four-fold, and additive effect against remaining strains (MIC gain = two-fold). Interesting synergistic interactions were observed by combining all studied EOs with fluconazole, with reduction rates of their MICs ranging from 16 to 512-fold. This synergistic effect was very pronounced with the combination of T. leptobotrys EO and fluconazole. These findings indicate that studied EOs can be used as anti-candidals in combination with antifungals, particularly fluconazole, to counteract the emergence of resistant Candida spp.

1. Introduction

The incidence of systemic fungal infections has been increasing significantly and currently affects millions of people worldwide [1,2,3]. Yeasts of Candida genus are reported to be responsible for 80% of fungal infections, which are recognized as one of the most common nosocomial contaminations, producing important morbidity and mortality rates, particularly in immunocompromised patients [4,5]. Within 200 yeast species, Candida albicans has been described as the most common pathogen found in severe candidiasis infections, but other non-albicans Candida spp. such as C. glabrata, C. tropicalis, C. krusei, and C. parapsilosis are becoming increasingly insidious [6,7,8]. The current treatment of these candidiasis infections remains essentially based on the use of common polyenes (e.g., amphotericin B) and azole antifungals (e.g., fluconazole), mainly targeting ergosterol in the fungal cell membrane or its biosynthetic pathway [9,10,11]. However, the fungistatic property of many of these antifungals, in addition to the increased therapy cost and the emergence of clinical drug resistance, limit their success in clinical practice [9,10,12,13]. The development of novel antifungal agents is becoming difficult and challenging due to the eukaryotic nature of Candida cells, which results in a limited number of drug targets. The required antifungals should be specific against the pathogen’s targets, which are not shared with human hosts; otherwise, these antifungals should display a selective toxicity to the fungal cell, while being safe towards the human host cell [14]. Alternatively, the synergy between conventional drugs and natural antimicrobial products has been described as an emerging strategy to minimize the effective doses of standard antifungals, minimizing their side effects and their related toxicity, while enhancing their biological efficacies [15,16]. Among natural products, essential oils (EOs) from medicinal plants constitute rich sources of bioactive compounds with strong antimicrobial activities and low cytotoxicity against the host [17]. Several EOs have been reported to present high synergistic interactions with conventional antimicrobials against several pathogenic micro-organisms, including polyene and azole-resistant Candida isolates [15,18,19]. In fact, many EO components target multiple metabolic pathways in Candida cells, which can overcome or delay the emergence of drug resistance [19,20,21]. Additionally, some terpenoids, when used in combination, are able to transform the fungistatic nature of fluconazole into a fungicidal drug, and to inhibit the antifungal efflux by blocking drug transporter pumps [15,18].
Thymus leptobotrys Murb. (Lamiaceae), T. pallidus Batt. (Lamiaceae), T. satureioides Coss. (Lamiaceae), Origanum compactum Benth. (Lamiaceae), Artemisia herba alba Asso. (Asteraceae) and Ammodaucus leucotrichus (Coss. &Durieu) (Apiaceae) are extensively used in Moroccan folk medicine in different forms to treat many fungal diseases [22]. Moreover, their antibacterial, antifungal, antiparasitic and antiviral activities have been reported in many previous studies [23,24,25,26,27,28]. To the best of our knowledge, no study has yet been published about synergistic interactions of their EOs with conventional antifungals. Therefore, the aim of the present work was to evaluate the capacity of these EOs to enhance the anticandidal effects of amphotericin B and fluconazole, when used in combination at significantly low concentrations, against four clinically isolated fungal strains, namely C. albicans, C. glabrata, C. krusei and C. parapsilosis.

2. Results and Discussion

2.1. Chemical Composition of the EOs

The EOs extracted by steam-distillation were found to be pale to dark yellow, except for A. leucotrichus EO which was blue, with yields ranging from (0.63 ± 0.05)% to (2.15 ± 0.02)% (v/w) based on dry weight (Table 1). Generally, the EO yields of dried aerial parts of T. pallidus and T. leptobotrys were similar to those reported previously [28,29], while the fruit of A. leucotrichus and the aerial parts of T. satureioides, O. compactum and A. herba alba yielded a lower number of EOs compared to those obtained in many previous works [23,25,26,27,29]. The results of the chemical analysis of the volatile constituents of the EOs (percentage content of each compound, elution order, retention index (RI), Retention time (RT) and structural subclass) are summarized in Table 2. Sixty-eight constituents were identified, which accounted for 94.34–99.20% of the total oils. Generally, the studied EOs were quantitatively dominated by oxygenated monoterpenes (41.65–92.64%), except T. pallidus EO which was dominated by monoterpene hydrocarbons (57.70%). GC-MS analysis revealed a high content of carvacrol (78.75%) in T. leptobotrys EO, which is in agreement with that previously reported in the literature [29,30]. The main constituents of T. pallidus EO were found to be γ-terpinene (29.6%), thymol (26.8%) and p-cymene (18.9%) (Table 2), which is in accordance with those reported in many previous works [31,32]. However, many other chemotypes dominated by camphene (7.5–17.7%), myrcene (1.1–15.4%) and camphor (28.5–29.8%) have been reported in T. pallidus EOs originating from other Moroccan regions [30,33]. The EO of O. compactum was dominated by carvacrol (35.69%), p-cymene (13.72%) and carvacrol methyl ether (11.69%). This chemical profile is similar to that obtained for EOs of some O. compactum samples harvested from different regions of northern Morocco [34]. Otherwise, γ-terpinene (8.72–17.25%) thymol (10.33–15.75%) and p-cymene (8.44–18.59%) were identified, beside carvacrol (43.58–47.85%), as main oil constituents of the plant in other Moroccan regions [25,35]. The main oil constituents from T. satureioides were carvacrol (25.45%), borneol (13.66%) and caryophyllene (12.10%), which is similar to what has been previously reported in the literature [31,33,36,37]. However, camphene (11.8%) and α-terpineol (10.4%), beside borneol (26.7%), were reported as major constituents of T. satureioides EO originating from the Imouzzer region [30]. Concerning A. leucotrichus EO, the main compounds were found to be l-perillaldehyde (46.63%), D-limonene (23.81%) and bornyl angelate (6.24%). This chemical profile is similar to those reported in previous studies, where perillaldehyde and limonene were found to be the major components of A. leucotrichus EO, while bornyl angelate was absent or present at a low concentration [38,39,40].
A. herba alba EO was dominated by cis-thujone (42.40%), trans-thujone (28.77%) and camphor (16.65%). This composition is qualitatively similar to that reported previously in some studies, but with some quantitative differences [41,42,43]. In contrast, another chemical profile dominated by chrysanthenone (47%) camphor (24%) and verbenone (7.2%) was reported for the EO of A. herba alba collected from Tahanaoute region [27].

2.2. Anticandidal Activity

The anticandidal activities of studied EOs towards Candida strains were evaluated using broth microdilution assays. The results given in Table 3 demonstrated that all EOs expressed strong anticandidal effects with MIC values ranging from 0.162 mg/mL to 4.950 mg/mL (Table 3). A. leucotrichus, O. compactum and T. leptobotrys EOs displayed the strongest inhibitory activity against all tested Candida strains, with comparative MIC values ranging from 0.162 mg/mL to 0.596 mg/mL. These values were, interestingly, lower than those of fluconazole (MIC = 1 mg/mL for all Candida strains). EOs of T. saturioiedes and T. pallidus expressed high anticandidal activities at concentrations ranging from 0.373 mg/mL to 2.598 mg/mL, while A. herba alba EO showed poor effect towards all tested strains, with MIC values between 2.475 mg/mL and 4.950 mg/mL.
The relatively strong activity of A. leucotrichus observed in our study is in line with those works reporting the effect of this oil on some Candida strains [28,44,45,46]. This strong activity can be mainly explained by the presence of high content of perillaldehyde, an oxygenated monoterpene previously tested for its potent antimicrobial activity [47,48,49]. O. compactum and Thymus species have long been known for their large spectrum of activity against numerous pathogenic strains [23,25,50]. Their antifungal effect is attributed to the presence of bioactive antimicrobial compounds, especially carvacrol, thymol, borneol, p-cymene and γ-terpinene. The anticandidal effect of these monoterpenoids has been well demonstrated, with carvacrol being more active than the other thyme oil constituents [15,51,52,53], and can explain the relative high activities of T. leptobotrys and O. compactum which contain higher percentages of this phenolic monoterpene compared to the remaining studied thymes. The moderate anticandidal effect of A. herba alba obtained in our study is consistent with that previously reported [41].

2.3. Synergistic Effect of EOs with Conventional Antifungals

The results of the synergistic interactions (FICI values and MIC gain of the antifungals) between studied EOs and conventional antifungals fluconazole and amphotericin B are reported in Table 4 andTable 5, respectively. The combinations of studied EOs and fluconazole gave very pronounced synergistic effects regarding all tested Candida strains, with FICI values between 0.25 and 0.31 (Table 4). Among these combinations, the one prepared by T. leptobotrys EO showed the greater synergism, with promising reduction in fluconazole MICs of Candida strains up to 512 fold. The addition of T. satureioides or T. pallidus EOs reduced the fluconazole MICs for C. albicans, C. glabrata and C. krusei by 456 fold and by 64 fold for C. parapsilosis. EOs of O. compactum and A. leucotrichus decreased the MIC values of fluconazole 128 fold for C. albicans and C. glabrata, 64 fold for C. krusei and 16 fold for C. parapsilosis, while A. herba alba EO reduced the fluconazole MICs for C. albicans, C. glabrata and C. krusei by 64 fold and C. parapsilosis by 32 fold. From these results, it can be observed that the synergistic effect of EOs with fluconazole was stronger than that obtained with amphotericin B (Table 5). Indeed, the combination of amphotericin B with sub-MICs of T. leptobotrys, A. herba alba or O. compactum EOs gave synergistic effects against C. krusei only, with FICI = 0.5 and four-fold gains, while additive effects (FICI = 0.75) and gains of two-fold were obtained against the other tested Candida strains. Remaining EOs gave MIC gains of 1 towards all tested Candida and FICI = 1.25, indicating indifferent outcome. Interestingly, for all combinations and for the two conventional antifungals studied, none was found to be antagonistic against the tested strains.
To the best of our knowledge, the combinations of the EOs and antifungals (fluconazole and amphotericin B) have not been investigated previously. However, the studied EOs are characterized by the presence of some major compounds known to possess strong antimicrobial effects and synergism interactions with many antimicrobials [20,54,55]. In fact, carvacrol and thymol (principal components of studied Origanum and Thymus EOs) were reported to interact with the cytoplasmic membrane by its entry between the acyl chains of phospholipids, leading to the disruption of its fluidity and permeability [20,56,57]. This mechanism may facilitate the permeability of fluconazole through the fungal membrane to the intracellular target, acting together on the ergosterol biosynthesis pathway. Carvacrol and thymol were reported to increase the effectiveness of fluconazole by chemo-sensitizing the Candida cells to the antifungal and decreasing its extrusion by efflux pumps [15].

3. Materials and Methods

3.1. Plant Material and EOs Extraction

Aerial parts of T. leptobotrys, T. pallidus, T. satureioides, O. compactum, A. herba alba and fruits of A. leucotrichus were collected from different wild locations in Morocco (Table 1) and identified by one of the authors (Abbad. A). Plants collected were dried in the shade at room temperature (≈25 °C) and voucher specimens were deposited at the Laboratory of Microbial Biotechnologies, Agrosciences and Environment of the Faculty of Science Semlalia, University Cadi Ayyad, Marrakech. Each dried plant material was submitted to four successive steam-distillations (4 × 200 g) for about 3 h using a Clevenger-type apparatus, and recovered EOs were dried with anhydrous sodium sulfate and stored in hermetically sealed vials at 4 °C until use.

3.2. GC/MS Analysis

Qualitative and quantitative analysis of the EO chemical compounds was carried out using a gas chromatograph equipped with a TG-5MS column (length: 30 m; internal diameter: 0.25 mm, thickness film: 0.25 mm) and coupled to a mass selective detector ISQ (Single Quadrupole Mass spectrometer). The carrier gas was helium with flow rate of 1.0 mL/min. EO samples (20 µL) were diluted in 2 mL of hexane and 2.0 μL of the dilution was injected, using split mode. The injection temperature was 260 °C and the column temperature was programmed from 100 to 260 °C at a rate of 4 °C/min with a hold of 10 min at 246 °C. The transfer line and ion source temperatures were held at 230 °C with EI ionization (70 eV) and the m/z scan range was of 41–500. Identification of the individual components was carried out by matching their mass spectra with WILEY275, NBS75K, and Adams terpene library [58], and standards of the main components where possible. For semi-quantification purposes, the normalized peak area of each compound was used without any correction factors to establish abundances.

3.3. Candida Strains

The yeast strains used in this study were provided by the Moroccan coordinated collection of microorganisms. C. albicans (CCMM L4), C. glabrata (CCMM L7), C. krusei (CCMM L10) and C. parapsilosis (CCMM L18) are clinically isolated fungal strains originating from patients suffering from acute candidiasis. They were cultured in Sabouraud Dextrose Agar at 28 °C for 48 h [59].

3.4. Determination of the Minimum Inhibitory Concentration (MIC)

The anticandidal activities of EOs were evaluated using broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines M27-A3 [60]. EO dilutions were performed in Sabouraud Dextrose Broth supplemented with dimethyl-sulfoxide (DMSO), at a final concentration of 1%, to enhance oil solubility. A negative control was prepared using the same concentration of DMSO. Then, 100 μL of each dilution was mixed with the same volume of cell suspension at 1–2 × 103 cells/mL. The microplates were incubated at 28 °C for 48 h and the MIC value was defined as the lowest EO concentration that inhibits macroscopic growth of the tested strains. Fluconazole and amphotericin B were used as positive controls.

3.5. Synergistic Effect of EOs with Conventional Antifungals

Synergistic interactions between conventional antifungals (fluconazole and amphotericin B) and EOs, were determined using microdilution assay [16]. Briefly, 50 μL of a serial dilution of antifungals (from MIC to 1/512 MIC) were added to microwells containing 50 μL of the EO at sub-inhibitory concentrations (1/4 MIC), and previously seeded by 100 μL of cell suspensions. The microplates were incubated at 28 °C for 48 h. The MIC values of antifungals in combination with sub-MICs of EOs were determined and fractional inhibitory concentration index (FICI) was calculated using the following formula: FICI = FIC of EO + FIC of antifungal
FIC of EO = MIC of EO in combination with antifungal/MIC of EO alone, and FIC of antifungal = MIC of antifungal in combination with EO/MIC of antifungal alone.
The FICI results were interpreted as: A synergism when (FICI ≤ 0.5), additive effects when (0.5 < FICI ≤ 1), indifference when (1 < FICI ≤ 2) or an antagonism when (FICI ≥ 2) [61].
The MIC gain of the antifungal was determined as MIC of antifungal alone/MIC of antifungal in combination with EO.

4. Conclusions

The present work provides new information regarding the anticandidal potential of some selected Moroccan EOs and their synergistic effects with two common antifungals (fluconazole and amphotericin B). The results indicate that all EOs studied possess anticandidal activity, with those extracted from A. leucotrichus, O. compactum and T. leptobotrys being more effective. The addition of the different EOs at sub-inhibitory concentration reduces the fluconazole and amphotericin B MICs of the tested Candida strains by 16 to 512-fold and one to four-fold, respectively. Among the EOs examined, T. leptobotrys EO combined high anticandidal effect and high synergistic interaction with two conventional antifungals, mainly fluconazole. These findings showed that the studied EOs, in particular T. leptobotrys EO, may be used as effective anticandidal agents to restore the efficacy of these common antifungal drugs for combating resistant-Candida strains. Additional studies are necessary to determine the mechanism of these synergistic antifungal associations.

Author Contributions

Conceptualization, B.S., L.H., N.-E.M. and A.A.; methodology, B.S. and A.A.; supervision, L.H. and A.A.; data curation, B.S. and E.V.; resources, M.I.; writing—original draft, B.S.; writing—review and editing, E.V. and M.I. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

Data is contained within the article.

Acknowledgments

We thank the “Haut Commissariat aux Eaux et Forêts et à la Lutte Contre la Désertication (HCEFLCD)” for permission to collect the plant materials from the field. We are grateful to Henrique D. M. Coutinho from the Regional University of Cariri, Brazil, for its assistance in the editing of the English manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Shapiro, R.S.; Robbins, N.; Cowen, L.E. Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol. Mol. Biol. Rev. 2011, 75, 213–267. [Google Scholar] [CrossRef] [Green Version]
  2. Anderson, J. Evolution of antifungal-drug resistance: Mechanisms and pathogen fitness. Nat. Rev. Microbiol. 2005, 3, 547–556. [Google Scholar] [CrossRef]
  3. Shao, P.L.; Huang, L.M.; Hsueh, P.R. Recent advances and challenges in the treatment of invasive fungal infections. Int. J. Antimicrob. Agents 2007, 30, 487–495. [Google Scholar] [CrossRef] [PubMed]
  4. De Repentigny, L.; Lewandowski, D.; Jolicoeur, P. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin. Microbiol. Rev. 2004, 17, 729–759. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Wisplinghoff, H.; Bischoff, T.; Tallent, S.; Seifert, H.; Wenzel, R.P.; Edmond, M.B. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nation wide surveillance study. Clin. Infect. Dis. 2004, 39, 309–317. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Filler, S.G.; Sheppard, D.C. Fungal invasion of normally non-phagocytic host cells. PLoS Pathog. 2006, 2, e129. [Google Scholar] [CrossRef]
  7. Nguyen, M.H.; Peacock, J.E.; Morris, A.J.; Tanner, D.C.; Nguyen, M.L.; Snydman, D.R.; Wagener, M.M.; Rinaldi, M.G.; Yu, V.L. The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance. Am. J. Med. 1996, 100, 617–623. [Google Scholar] [CrossRef]
  8. Bojic-Milicevic, G.; Mikov, M.; Golocorbin-Kohn, S. The importance of genus Candida in human samples. Zb. Matice Srp. Za Prir. Nauk. 2008, 79–95. [Google Scholar] [CrossRef]
  9. Prasad, R.; Shah, A.H.; Rawal, M.K. Antifungals: Mechanism of action and drug resistance. Adv. Exp. Med. Biol. 2016, 892, 327–349. [Google Scholar] [CrossRef]
  10. Lupetti, A.; Danesi, R.; Campa, M.; Del Tacca, M.; Kelly, S. Molecular basis of resistance to azole antifungals. Trends Mol. Med. 2002, 8, 76–81. [Google Scholar] [CrossRef]
  11. Spampinato, C.; Leonardi, D. Candida infections, causes, targets, and resistance mechanisms: Traditional and alternative antifungal agents. BioMed Res. Int. 2013, 2013, 204237. [Google Scholar] [CrossRef] [Green Version]
  12. Rex, J.H.; Rinaldi, M.G.; Pfaller, M.A. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 1995, 39, 1–8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Herbrecht, R.; Natarajan-Amé, S.; Nivoix, Y.; Letscher-Bru, V. The lipid formulations of amphotericin B. Expert Opin. Pharmacother. 2003, 4, 1277–1287. [Google Scholar] [CrossRef]
  14. Ahmad, A.; Molepo, J.; Patel, M. Challenges in the development of antifungal agents against Candida: Scope of phytochemical research. Curr. Pharm. Des. 2016, 22, 4135–4150. [Google Scholar] [CrossRef] [PubMed]
  15. Ahmad, A.; Khan, A.; Manzoor, N. Reversal of efflux mediated antifungal resistance underlies synergistic activity of two monoterpenes with fluconazole. Eur. J. Pharm. Sci. 2013, 48, 80–86. [Google Scholar] [CrossRef] [PubMed]
  16. Soulaimani, B.; Nafis, A.; Kasrati, A.; Rochdi, A.; Mezrioui, N.E.; Abbad, A.; Hassani, L. Chemical composition, antimicrobial activity and synergistic potential of essential oil from endemic Lavandula maroccana (Mill.). S. Afr. J. Bot. 2019, 125, 202–206. [Google Scholar] [CrossRef]
  17. Azzimonti, B.; Cochis, A.; El Beyrouthy, M.; Iriti, M.; Uberti, F.; Sorrentino, R.; Landini, M.M.; Rimondini, L.; Varoni, E.M. Essential oil from berries of Lebanese Juniperus excelsa M. Bieb displays similar antibacterial activity to chlorhexidine but higher cytocompatibility with human oral primary cells. Molecules 2015, 20, 9344–9357. [Google Scholar] [CrossRef] [Green Version]
  18. Ahmad, A.; Khan, A.; Khan, L.A.; Manzoor, N. In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates. J. Med. Microbiol. 2010, 59, 1178–1184. [Google Scholar] [CrossRef] [PubMed]
  19. Khan, M.S.A.; Malik, A.; Ahmad, I. Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans. Med. Mycol. 2012, 50, 33–42. [Google Scholar] [CrossRef] [Green Version]
  20. Ahmad, A.; Khan, A.; Akhtar, F.; Yousuf, S.; Xess, I.; Khan, L.A.; Manzoor, N. Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida. Eur. J. Clin. Microbiol. Infect. Dis. 2011, 30, 41–50. [Google Scholar] [CrossRef]
  21. Khan, A.; Ahmad, A.; Akhtar, F.; Yousuf, S.; Xess, I.; Khan, L.A.; Manzoor, N. Ocimum sanctum essential oil and its active principles exert their antifungal activity by disrupting ergosterol biosynthesis and membrane integrity. Res. Microbiol. 2010, 161, 816–823. [Google Scholar] [CrossRef]
  22. Bellakhdar, J. La Pharmacopée Marocaine Traditionnelle, Médicine Arabe Ancienne et Savoirs Populaire; Ibis Press: Paris, France, 1997. [Google Scholar]
  23. El Abdouni Khayari, M.; Jamali, C.A.; Kasrati, A.; Hassani, L.; Leach, D.; Markouk, M.; Abbad, A. Antibacterial activity of essential oils of some moroccan aromatic herbs against selected food-related bacteria. J. Essent. Oil-Bear. Plants 2016, 19, 1075–1085. [Google Scholar] [CrossRef]
  24. Alaoui Jamali, C.; Kasrati, A.; Fadli, M.; Hassani, L.; Leach, D.; Abbad, A. Synergistic effects of three Moroccan thyme essential oils with antibiotic cefixime. Phytothérapie 2017. [Google Scholar] [CrossRef]
  25. Ouedrhiri, W.; Balouiri, M.; Bouhdid, S.; Moja, S.; Chahdi, F.O.; Taleb, M.; Greche, H. Mixture design of Origanum compactum, Origanum majorana and Thymus serpyllum essential oils: Optimization of their antibacterial effect. Ind. Crop. Prod. 2016, 89, 1–9. [Google Scholar] [CrossRef]
  26. Fadli, M.; Pagès, J.; Mezrioui, N.; Abbad, A. Artemisia herba-alba Asso and Cymbopogon citratus (DC.) Stapf essential oils and their capability to restore antibiotics efficacy. Ind. Crop. Prod. 2016, 89, 399–404. [Google Scholar] [CrossRef]
  27. Benchikha, N.; Rebiai, A.; Brahima, O.; Neghmouch, N.S.; Ben Amor, M.L. Chemical composition, antimicrobial, antioxidant and anticancer activities of essential oil from Ammodaucus leucotrichus Cosson & Durieu (Apiaceae) growing in south Algeria. Bull. Chem. Soc. Ethiop. 2019, 33, 541–549. [Google Scholar] [CrossRef]
  28. Soulaimani, B.; El Hidar, N.; Ben El Fakir, S.; Mezrioui, N.; Hassani, L.; Abbad, A. Combined antibacterial activity of essential oils extracted from Lavandula maroccana (Murb.), Thymus pallidus Batt. and Rosmarinus officinalis L. against antibiotic-resistant Gram-negative bacteria. Eur. J. Integr. Med. 2021, 43, 101312. [Google Scholar] [CrossRef]
  29. Boubaker, H.; Karim, H.; El Hamdaoui, A.; Msanda, F.; Leach, D.; Bombarda, I.; Vanloot, P.; Abbad, A.; Boudyach, E.H.; Ait Ben Aoumar, A. Chemical characterization and antifungal activities of four Thymus species essential oils against postharvest fungal pathogens of citrus. Ind. Crop. Prod. 2016, 86, 95–101. [Google Scholar] [CrossRef]
  30. El Asbahani, A.; Jilale, A.; Voisin, S.N.; Aït Addi, E.H.; Casabianca, H.; El Mousadik, A.; Hartmann, D.J.; Renaud, F.N.R. Chemical composition and antimicrobial activity of nine essential oils obtained by steam distillation of plants from the Souss-Massa Region (Morocco). J. Essent. Oil Res. 2015, 27, 34–44. [Google Scholar] [CrossRef]
  31. Alaoui Jamali, C.; El Bouzidi, L.; Bekkouche, K.; Hassani, L.; Markouk, M.; Wohlmuthc, H.; Leach, D.; Abbad, A. Chemical composition and antioxidant and anticandidal activities of essential oils from different wild moroccan Thymus species. Chem. Biodivers. 2012, 9, 1188–1197. [Google Scholar] [CrossRef]
  32. Fadli, M.; Chevalier, J.; Saad, A.; Mezrioui, N.E.; Hassani, L.; Pages, J.M. Essential oils from Moroccan plants as potential chemosensitisers restoring antibiotic activity in resistant Gram-negative bacteria. Int. J. Antimicrob. Agents 2011, 38, 325–330. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Ghalbane, I.; Belaqziz, R.; Ait Said, L.; Oufdou, K.; Romane, A.; El Messoussi, S. Chemical composition, antibacterial and antioxidant activities of the essential oils from Thymus satureioides and Thymus pallidus. Nat. Prod. Commun. 2011, 6, 1507–1510. [Google Scholar] [CrossRef] [Green Version]
  34. Laghmouchi, Y.; Belmehdi, O.; Senhaji, N.S.; Abrini, J. Chemical composition and antibacterial activity of Origanum compactum Benth. essential oils from different areas at northern Morocco. S. Afr. J. Bot. 2018, 115, 120–125. [Google Scholar] [CrossRef]
  35. Bouyahya, A.; Dakka, N.; Talbaoui, A.; Et-Touys, A.; El-Boury, H.; Abrini, J.; Bakri, Y. Correlation between phenological changes, chemical composition and biological activities of the essential oil from Moroccan endemic Oregano (Origanum compactum Benth). Ind. Crop. Prod. 2017, 108, 729–737. [Google Scholar] [CrossRef]
  36. El Bouzidi, L.; Jamali, C.A.; Bekkouche, K.; Hassani, L.; Wohlmuth, H.; Leach, D.; Abbad, A. Chemical composition, antioxidant and antimicrobial activities of essential oils obtained from wild and cultivated Moroccan Thymus species. Ind. Crop. Prod. 2013, 43, 450–456. [Google Scholar] [CrossRef]
  37. Chraibi, M.; Farah, A.; Lebrazi, S.; El Amine, O.; Iraqui Houssaini, M.; Fikri-Benbrahim, K. Antimycobacterial natural products from Moroccan medicinal plants: Chemical composition, bacteriostatic and bactericidal profile of Thymus satureioides and Mentha pulegium essential oils. Asian Pac. J. Trop. Biomed. 2016, 6, 836–840. [Google Scholar] [CrossRef] [Green Version]
  38. Sadaoui, N.; Bec, N.; Barragan-Montero, V.; Kadri, N.; Cuisinier, F.; Larroque, C.; Arab, K.; Khettal, B. The essential oil of Algerian Ammodaucus leucotrichus Coss. & Dur. and its effect on the cholinesterase and monoamine oxidase activities. Fitoterapia 2018, 130, 1–5. [Google Scholar] [CrossRef]
  39. Khaldi, A.; Meddah, B.; Moussaoui, A.; Sonnet, P. Anti-mycotoxin effect and antifungal properties of essential oil from Ammodaucus leucotrichus Coss. & Dur. on Aspergillus flavus and Aspergillus ochraceus. J. Essent. Oil-Bear. Plants 2017, 20, 36–44. [Google Scholar] [CrossRef]
  40. Manssouri, M.; Znini, M.; El Harrak, A.; Majidi, L. Antifungal activity of essential oil from the fruits of Ammodaucus leucotrichus Coss. & Dur., in liquid and vapour phase against postharvest phytopathogenic fungi in apples. J. Appl. Pharm. Sci. 2016, 6, 131–136. [Google Scholar] [CrossRef] [Green Version]
  41. Abu-darwish, M.S.; Cabral, C.; Gonçalves, M.J.; Cavaleiro, C.; Cruz, M.T. Artemisia herba-alba essential oil from Buseirah (South Jordan): Chemical characterization and assessment of safe antifungal and anti-in fl ammatory doses. J. Ethnopharmacol. 2015, 174, 153–160. [Google Scholar] [CrossRef]
  42. Bertella, A.; Benlahcen, K.; Abouamama, S.; Pinto, D.C.G.A.; Maamar, K.; Kihal, M.; Silva, A.M.S. Artemisia herba-alba Asso. essential oil antibacterial activity and acute toxicity. Ind. Crop. Prod. 2018, 116, 137–143. [Google Scholar] [CrossRef]
  43. Amor, G.; Caputo, L.; La Storia, A.; De Feo, V.; Mauriello, G.; Fechtali, T. Artemisia herba-alba and Origanum majorana Essential Oils from Morocco. Molecules 2019, 24, 4021. [Google Scholar] [CrossRef] [Green Version]
  44. Mohammedi, H.; Idjeri-Mecherara, S.; Menaceur, F.; Azine, K.; Hassani, A. Chemical compositions of extracted volatile oils of Ammodaucus leucotrichus L. fruit from different geographical regions of Algeria with evaluation of its toxicity, anti-inflammatory and antimicrobial activities. J. Essent. Oil-Bear. Plants 2018, 21, 1568–1584. [Google Scholar] [CrossRef]
  45. Louail, Z.; Kameli, A.; Benabdelkader, T.; Bouti, K.; Hamza, K.; Krimat, S. Antimicrobial and antioxidant activity of essential oil of Ammodaucus leucotrichus Coss. & Dur. seeds. J. Mater. Environ. Sci. 2016, 7, 2689–2695. [Google Scholar]
  46. El-Haci, I.; Bekhechi, C.; Atik-Bekkara, F.; Mazari, W.; Gherib, M.; Bighelli, A.; Csanova, J.; Tomi, F. Antimicrobial activity of Ammodaucus leucotrichus fruit oil from algerian sahara. Nat. Prod. Commun. 2014, 9, 711–712. [Google Scholar] [CrossRef] [Green Version]
  47. Mcgeady, P.; Wansley, D.L.; Logan, D.A. Filamentous structures in Candida significant inhibition of growth. J. Nat. Prod. 2002, 65, 11–13. [Google Scholar]
  48. Tian, J.; Wang, Y.; Zeng, H.; Li, Z.; Zhang, P.; Tessema, A.; Peng, X. Efficacy and possible mechanisms of perillaldehyde in control of Aspergillus niger causing grape decay. Int. J. Food Microbiol. 2015, 202, 27–34. [Google Scholar] [CrossRef] [PubMed]
  49. Tian, J.; Zeng, X.; Lü, A.; Zhu, A.; Peng, X.; Wang, Y. Perillaldehyde, a potential preservative agent in foods: Assessment of antifungal activity against microbial spoilage of cherry tomatoes. LWT—Food Sci. Technol. 2015, 60, 63–70. [Google Scholar] [CrossRef]
  50. Asdadi, A.; Alilou, H.; Akssira, M.; Mina, L.; Hassani, I.; Chebli, B. Chemical composition and anticandidal effect of three Thymus species essential oils from southwest of Morocco against the emerging nosocomial fluconazole-resistant strains. Biol. Agric. Healthc. 2014, 4, 16–27. [Google Scholar]
  51. Burt, S.A.; Vlielander, R.; Haagsman, H.P.; Veldhuizen, E.J.A. Increase in activity of essential oil components carvacrol and thymol against Escherichia coli O157:H7 by addition of food stabilizers. J. Food Prot. 2005, 68, 919–926. [Google Scholar] [CrossRef] [PubMed]
  52. Lambert, R.J.; Skandamis, P.; Coote, P.; Nychas, G.-J. A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. J. Appl. Microbiol. 2001, 91, 453–462. [Google Scholar] [CrossRef] [Green Version]
  53. Saad, N.Y.; Muller, D.; Lobstein, A. Major bioactivities and mechanism of action of essential oils and their components. Flavour Fragr. J. 2013, 28, 269–279. [Google Scholar] [CrossRef]
  54. Rajput, S.B.; Mohan Karuppayil, S. Small molecules inhibit growth, viability and ergosterol biosynthesis in Candida albicans. Springerplus 2013, 2, 1–6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Palaniappan, K.; Holley, R.A. International Journal of Food Microbiology Use of natural antimicrobials to increase antibiotic susceptibility of drug resistant bacteria. Int. J. Food Microbiol. 2010, 140, 164–168. [Google Scholar] [CrossRef] [PubMed]
  56. Di Pasqua, R.; Betts, G.; Hoskins, N.; Edwards, M.; Ercolini, D.; Mauriello, G. Membrane toxicity of antimicrobial compounds from essential oils. J. Agric. Food Chem. 2007, 55, 4863–4870. [Google Scholar] [CrossRef]
  57. Ultee, A.; Bennik, M.H.J.; Moezelaar, R. The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus. Appl. Environ. Microbiol. 2002, 68, 1561–1568. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Adams, R.P. Identification of Essential Oil Coponents by Gaz Chromatography; Allured Publishing Corporation: Carol Stream, IL, USA, 2007; Volume 456. [Google Scholar]
  59. Saad, A.; Fadli, M.; Bouaziz, M.; Benharref, A.; Mezrioui, N.E.; Hassani, L. Anticandidal activity of the essential oils of Thymus maroccanus and Thymus broussonetii and their synergism with amphotericin B and fluconazol. Phytomedicine 2010, 17, 1057–1060. [Google Scholar] [CrossRef]
  60. Clinical and Laboratory Standards Institute (CLSI). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard M27-A3, 3rd ed.; CLSI: Wayne, PA, USA, 2008. [Google Scholar]
  61. European Commitee for Antimicrobial Susceptibility Testing (EUCAST). Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin. Microbiol. Infect. 2000, 6, 503–508. [Google Scholar] [CrossRef] [Green Version]
Table
Table 1. Local names, harvesting location and period, voucher specimens and EO yield for the studied plants.
Table 1. Local names, harvesting location and period, voucher specimens and EO yield for the studied plants.
Plant SpeciesLocal NamesHarvesting PlaceHarvesting TimeVoucher SpecimensLatitude/LongitudeOil Yields a (%)
T. leptobotrysZa-itraTafraouteMay 2019TL-0329°42′ N/08°74′ W1.85 ± 0.07
T. saturioiedesZa-itraIdniMay 2019TS-0630°54′ N/08°17′ W0.66 ± 0.08
T. pallidusZa-itraAit LkakJune 2019TP-1331°17′ N/07°50′ W2.15 ± 0.02
O. compactumZaatarTouflihtJune 2018OC-1231°28′ N/07°32′ W0.63 ± 0.05
A. leucotrichusKemoune essoufiTataJune 2018AL-1729°44′ N/07°54′ W1.25 ± 0.07
A. herba albaSheehIjoukakSeptember 2019AHA-1830°59′ N/8°09′ W0.81 ± 0.01
a Yield of EOs determined based on their volume/weight of the sample used for distillation.
Table
Table 2. Chemical compounds of studied EOs.
Table 2. Chemical compounds of studied EOs.
RT aRI bCompounds cTlTpTsOcAlAha
2.70928α-Thujene0.291.400.310.41- d-
2.78931α-Pinene0.261.302.820.524.20-
2.92950Camphene-2.204.110.140.151.63
3.029751-Octen-3-ol0.100.30-0.22--
3.109833-Octanone0.11-----
3.12989Sabinene----0.16-
3.17992Myrcene0.710.901.891.21--
3.411005α-Phellandrene---0.13-
3.521019α-Terpinene-2.700.751.26--
3.621027p-Cymene1.9118.909.5013.72-0.64
3.671030d-Limonene-0.70--23.81-
3.7310311.8-Cineole-----0.85
3.811047Ocimene---0.30-
4.031057γ-Terpinene1.4429.606.708.970.91-
4.171067trans-Sabinene hydrate0.40--0.51--
4.531098Linalool0.524.707.792.370.41-
4.781108cis-Thujone2.56----42.40
4.951118trans-Thujone1.98----28.77
5.091127Chrysanthenone-----0.91
5.501146Camphor0.62---0.4216.65
5.871169Borneol0.645.4013.660.400.251.72
6.061180l-terpinen-4-ol0.55-0.980.46-0.65
6.141188α-Terpineol--3.951.02-
6.291197Caranone--0.33---
6.421200Dihydro-carvone0.18-0.20---
6.741213Verbenone-----0.69
7.141230Thymol methyl ether---0.12--
7.361241Cumin-aldehyde----3.83-
7.371244Carvacrol methyl ether---11.69--
7.541257Linalyl acetate----0.84-
7.781260Chrysanthenyl acetate0.12----1.00
8.221275l-Perillaldehyde----46.63-
8.3912861.4-p-Menthadien-7-al----1.73-
8.401288Thymol0.8526.8-1.20--
8.411289Bornyl acetate--1.32---
8.5412902-Caren-10-al----1.53-
8.681301Perrilla alcohol----0.28-
8.691303Carvacrol78.751.4025.4535.69-0.30
9.0513292-Methoxy-4-vinylphenol0.32-----
10.501366Carvacrol acetate0.21-- --
10.671370Ylangene---0.13--
10.781375α-Copaene---0.55--
11.051389(−)-β-Bourbonene---0.26--
11.181397Methyl perillate----1.51-
11.681413α-Gurjenene--0.10---
11.981415Caryophyllene1.602.9012.104.090.30-
12.211425β-Gurjunene-- 0.24--
12.351445Aromandendrene0.62-0.111.60--
12.501452Humulene--0.640.42--
13.071462epi-β-Caryophyllene0.15--0.12--
13.091464γ-Decalactone----0.19-
13.451484γ-Murolene---1.02--
13.621489Germacrene D0.26--0.420.27-
14.001500Viridi-florene0.56--1.63--
14.161504β-Himachalene--- 0.57-
14.251511β-Bisabolene---1.53--
14.481518Cubebol0.11-----
14.491519γ-Cadinene--0.510.82--
14.711526Cadina-1(10).4-diene0.21--2.16--
15.111531α-Cadinene---0.17--
15.741550Bornyl angelate----6.24-
16.231580(+)-Spatulenol0.33--0.86--
16.341589cis-Davanone0.73----2.34
16.391591Viridiflorol0.39-----
16.631598Caryophyllene oxide--1.131.03--
17.891649τ-Cadinol----0.64-
18.971685α-Bisabolol----0.33-
19.261700Shyobunol----0.83
Oxygen-containing monoterpenes87.0538.3052.0341.6555.2792.64
Monoterpene hydrocarbons4.6157.7026.0726.6629.232.27
Oxygen-containing sesquiterpenes1.560.001.131.898.042.34
Sesquiterpene hydrocarbons3.402.9013.4615.161.140.00
Other0.860.301.5812.032.351.00
Total97.4899.2094.3497.3996.0398.25
Tl: T. leptobotrys, Tp: T. pallidus, Ts: T. satureioides, Oc: O. compactum, Al: A. leucotrichus, Aha: A. herba alba. a RT retention times. b Retention indices determined using the homologous series of n-alkanes. c Compounds listed in order of elution.d Not detected.
Table
Table 3. Minimal inhibitory concentrations (MIC) of essential oils and two conventional antifungals (mg/mL).
Table 3. Minimal inhibitory concentrations (MIC) of essential oils and two conventional antifungals (mg/mL).
MicroorganismsTl aTsTpOcAlAhaFluconazoleAmphoterecin B
C. albicans0.5960.5982.5980.2780.3242.47510.0001
C. glabrata0.2970.3730.6440.2780.1624.95010.0001
C. krusei0.2971.1961.2990.2780.1624.95010.0001
C. parapsilosis0.2971.1960.6440.2780.1624.95010.0004
a The abbreviations of the species are given in Table 2.
Table
Table 4. Fractional inhibitory concentrations indices (FICIs) and gain of fluconazole combined with the essential oils.
Table 4. Fractional inhibitory concentrations indices (FICIs) and gain of fluconazole combined with the essential oils.
EOsC. albicansC. glabrataC. kruseiC. parapsilosis
MICF/MICCGainFICIMICF/MICCGainFICIMICF/MICCGainFICIMICF/MICCGainFICI
Tl1/0.0025120.25 a1/0.0025120.25 a1/0.0025120.25 a1/0.0025120.25 a
Ts1/0.0042560.25 a1/0.0042560.25 a1/0.0042560.25 a1/0.016640.27 a
Tp1/0.0042560.25 a1/0.0042560.25 a1/0.0042560.25 a1/0.016640.27 a
Oc1/0.0081280,26 a1/0.0081280.26 a1/0.016640.27 a1/0.062160.31 a
Al1/0.0081280.26 a1/0.0081280.26 a1/0.031320.28 a1/0.062160.31 a
Aha1/0.016640.27 a1/0.016640.27 a1/0.016640.27 a1/0.031320.28 a
MICF/MICC: MIC of Fluconazole alone/MIC of Fluconazole in combination with essential oil in mg/mL. a Synergism.
Table
Table 5. Fractional inhibitory concentrations indices (FICIs) and gain of amphoterecin B combined with the essential oils.
Table 5. Fractional inhibitory concentrations indices (FICIs) and gain of amphoterecin B combined with the essential oils.
EOsC. albicansC. glabrataC. kruseiC. parapsilosis
MICA/MICCGainFICIMICA/MICCGainFICIMICA/MICCGainFICIMICA/MICCGainFICI
Tl0.0001/0.0000520.75 b0.0001/0.0000520.75 b0.0001/0.0000340.50 a0.0004/0.000220.75 b
Ts0.0001/0.000111.25 c0.0001/0.000111.25 c0.0001/0.000111.25 c0.0004/0.000411.25 c
Tp0.0001/0.000111.25 c0.0001/0.000111.25 c0.0001/0.000111.25 c0.0004/0.000411.25 c
Oc0.0001/0.0000520.75 b0.0001/0.0000520.75 b0.0001/0.0000340.50 a0.0004/0.000220.75 b
Al0.0001/0.000111.25 c0.0001/0.000111.25 c0.0001/0.000111.25 c0.0004/0.000411.25 c
Aha0.0001/0.0000520.75 b0.0001/0.0000520.75 b0.0001/0.0000340.50 a0.0004/0.000220.75 b
MICA/MICC: MIC of Amphoterecin B alone/MIC of Amphoterecin B in combination with essential oil in mg/mL. a Synergism; b Additive effect; c Indifference.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Soulaimani, B.; Varoni, E.; Iriti, M.; Mezrioui, N.-E.; Hassani, L.; Abbad, A. Synergistic Anticandidal Effects of Six Essential Oils in Combination with Fluconazole or Amphotericin B against Four Clinically Isolated Candida Strains. Antibiotics 2021, 10, 1049. https://doi.org/10.3390/antibiotics10091049

AMA Style

Soulaimani B, Varoni E, Iriti M, Mezrioui N-E, Hassani L, Abbad A. Synergistic Anticandidal Effects of Six Essential Oils in Combination with Fluconazole or Amphotericin B against Four Clinically Isolated Candida Strains. Antibiotics. 2021; 10(9):1049. https://doi.org/10.3390/antibiotics10091049

Chicago/Turabian Style

Soulaimani, Bouchra, Elena Varoni, Marcello Iriti, Nour-Eddine Mezrioui, Lahcen Hassani, and Abdelaziz Abbad. 2021. "Synergistic Anticandidal Effects of Six Essential Oils in Combination with Fluconazole or Amphotericin B against Four Clinically Isolated Candida Strains" Antibiotics 10, no. 9: 1049. https://doi.org/10.3390/antibiotics10091049

APA Style

Soulaimani, B., Varoni, E., Iriti, M., Mezrioui, N. -E., Hassani, L., & Abbad, A. (2021). Synergistic Anticandidal Effects of Six Essential Oils in Combination with Fluconazole or Amphotericin B against Four Clinically Isolated Candida Strains. Antibiotics, 10(9), 1049. https://doi.org/10.3390/antibiotics10091049

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop